In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 4, 2009, Pages 810-814

  Alhanout, Kamel ^a   Brunel, Jean Michel ^a   Raoult, Didier ^a   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Antibiotics; Infections; Squalamine

Indexed keywords

1 [7 (1,4 DIAMINOBUTANE) CHOLEST 5 ENE 3BETA OL]; 2 [7 BETA (1,4 DIAMINOBUTANE) CHOLESTAN 3 BETA OL]; AMOXICILLIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; IMIPENEM; SQUALAMINE; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG STRUCTURE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CHOLESTANOLS; COLISTIN; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 70349462581     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp281     Document Type: Article

References (10)

1. Davies JC, Bilton D. Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 2009; 54: 628-40.
2. Touw DJ, Brimicombe RW, Hodson ME et al. Inhalation of antibiotics in cystic fibrosis. Eur Respir J 1995; 8: 1594-604.
3. Salmi C, Brunel JM. Therapeutic potential of cationic steroid antibacterials. Expert Opin Investig Drugs 2007; 16: 1143-57.
4. Herbst RS, Hammond LA, Carbone DP et al. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Clin Cancer Res 2003; 9: 4108-15.
5. Loncle C, Salmi C, Vidal N et al. Synthesis of new 7-aminosterol squalamine analogues with high antimicrobial activities through a stereoselective titanium reductive amination reaction. Eur J Med Chem 2007; 43: 540-7.
6. Adekambi T, Drancourt M, Raoult D. The rpoB gene as a tool for clinical microbiologists. Trends Microbiol 2009; 17: 37-45.
7. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
8. Salmi C, Loncle C, Vidal N et al. Squalamine: An appropriate strategy against the emergence of multidrug resistant Gram-negative bacteria? PLoS ONE 2008; 3: E2765.
9. Li J, Nation RL, Milne RW et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005; 25: 11-25.
10. Llobet E, Tomas JM, Bengoechea JA. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 2008; 154: 3877-86.